Related Experiment Video
Updated: May 27, 2026
13:41
Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
Published on: March 8, 2012
A new PCR-based mass spectrometry system for high-risk HPV, part I: methods
Xin Yi1, Jingjing Li, Shuang Yu
1Beijing Institute of Genomics, Chinese Academy of Sciences, Beijing, China.
American Journal of Clinical Pathology
|November 19, 2011
Summary
A new MassARRAY method accurately detects 14 high-risk human papillomaviruses (HPVs) linked to cervical cancer. This sensitive, high-throughput assay is ideal for large-scale studies and diagnostics.
Area of Science:
- Oncology
- Virology
- Molecular Diagnostics
Background:
- High-risk human papillomaviruses (HPVs) are the primary cause of cervical cancer.
- Establishing the link between specific HPV types and cervical cancer risk is crucial for prevention and treatment.
Purpose of the Study:
- To develop and validate a novel, simultaneous genotyping method for 14 high-risk HPV types.
- To assess the sensitivity, specificity, and throughput of the developed HPV genotyping assay.
Main Methods:
- Utilized MassARRAY technology based on matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry (MS).
- Developed a multiplex assay capable of detecting 14 distinct high-risk HPV genotypes concurrently.
Main Results:
- The assay demonstrated high specificity and sensitivity for all 14 HPV types in plasmid testing.
- Lower detection limits ranged from 10 to 100 copies per genotype.
- The MS system exhibited high-throughput capacity, processing up to 4,500 samples daily with type-specific output.
Conclusions:
- The MassARRAY-based HPV genotyping assay is a sensitive and effective tool for identifying high-risk HPV types.
- Its high-throughput capability, sensitivity, and cost-effectiveness make it suitable for large-scale epidemiological research and routine clinical diagnostics.
